Marshall Wace’s GenMark Diagnostics, Inc GNMK Stock Holding History

Marshall Wace’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,868	Closed	-$809K	–	3513
2021 Q1	$809K	Buy	+33,868	New	+$629K	﹤0.01%	1763
2019 Q1	–	Sell	-13,131	Closed	-$64K	–	2193
2018 Q4	$64K	Buy	+13,131	New	+$68.4K	﹤0.01%	1423
2016 Q4	–	Sell	-33,938	Closed	-$400K	–	1181
2016 Q3	$400K	Buy	+33,938	New	+$328K	﹤0.01%	828
2014 Q2	–	Sell	-127,474	Closed	-$1.27M	–	1116
2014 Q1	$1.27M	Buy	+127,474	New	+$1.58M	0.02%	452

Marshall Wace's GNMK Position: Q2 2021 in Review

Marshall Wace sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 33,868 shares — an estimated $809K sold.

Marshall Wace first reported a position in GNMK in Q1 2014 and held it in 4 quarters. The position peaked at $1.27M in Q1 2014. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Marshall Wace reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 33,868 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $809K.
Marshall Wace first reported a position in GenMark Diagnostics, Inc in Q1 2014 and held it in 4 quarters.
Marshall Wace's GenMark Diagnostics, Inc position peaked at $1.27M in Q1 2014.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.